Document Detail


Tissue perfusion and oxygenation with blood substitutes.
MedLine Citation:
PMID:  10837788     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
As an alternative to transfusion of red blood cells, intravenously (iv) administered artificial oxygen (O(2)) carriers are intended to increase the reduced O(2) carrying capacity of blood in the case of acute severe anemia, i.e. hemorrhagic shock or extreme normovolemic hemodilution (ANH). Actually, two groups of artificial O(2) carriers are investigated: ultrapurified, stroma-free hemoglobin solutions (SFH) of human or bovine origin and synthetically produced perfluorocarbons (PFC). SFH may be administered in large amounts and are suitable for 1:1 replacement of blood losses in case of hemorrhage as well as for isovolemic exchange of blood during ANH. In both situations SFH solutions effectively restore (hemorrhagic shock) and maintain (extreme ANH) tissue oxygenation despite extremely low hematocrit values. The vasopressor property of the isolated Hb molecule leads to a species-dependent (rodent>pig>human) increase in systemic and pulmonary vascular resistance, but leaves overall distribution of cardiac output uninfluenced. Due to the particulate nature of PFC emulsions, iv administration has to be restricted to small doses (3-4.5 ml/kg body weight for the actually investigated 60% w/v perflubron emulsion) in order to avoid overload of the reticuloendothelial system. Thus PFC emulsions are unsuitable for isovolemic blood replacement in hemorrhagic shock or ANH. Low-dose iv PFC administration in already hemodiluted subjects, however, creates an additional margin of safety to guarantee adequate tissue oxygenation which allows for further, extreme ANH, without risking tissue hypoxia.
Authors:
O P Habler; K F Messmer
Related Documents :
3677768 - Early diagnosis of shock due to pericardial tamponade using transcutaneous oxygen monit...
8087238 - Trauma and military applications of blood substitutes.
3516438 - Histamine level changes in the plasma and tissues in hemorrhagic shock.
7525918 - Redistribution of organ blood flow after hemorrhage and resuscitation in full-term pigl...
15382028 - Efficacy of mitotracker green and cmxrosamine to measure changes in mitochondrial membr...
2786078 - Transient postpartum amaurosis. a report of four cases.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Advanced drug delivery reviews     Volume:  40     ISSN:  0169-409X     ISO Abbreviation:  Adv. Drug Deliv. Rev.     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-07-18     Completed Date:  2000-07-18     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8710523     Medline TA:  Adv Drug Deliv Rev     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  171-84     Citation Subset:  IM    
Affiliation:
Institute of Anesthesiology, Ludwig-Maximilians-University, Munich, Germany. habler@icf.med.uni-muenchen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Substitutes / administration & dosage,  pharmacology*
Cattle
Humans
Oxygen / blood*
Oxygen Consumption / drug effects*
Perfusion
Chemical
Reg. No./Substance:
0/Blood Substitutes; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers...
Next Document:  Current aspects in pharmacology of modified hemoglobins.